These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6282216)

  • 61. Elimination kinetics of cefotaxime and desacetyl cefotaxime in patients with renal insufficiency and during hemodialysis.
    Ohkawa M; Okasho A; Motoi I; Tokunaga S; Shoda R; Kawaguchi S; Sawaki M; Shimamura M; Hirano S; Kuroda K; Awazu S
    Chemotherapy; 1983; 29(1):4-12. PubMed ID: 6299656
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of body weight on gentamicin pharmacokinetics in neonates.
    Zenk KE; Miwa L; Cohen JL; Waffarn F; Huxtable RF
    Clin Pharm; 1984; 3(2):170-3. PubMed ID: 6723222
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The use of cefotaxime (Claforan) in severe childhood infections].
    Boda D; Gyurkovits K
    Orv Hetil; 1984 Sep; 125(40):2431-2, 2435-6. PubMed ID: 6091016
    [No Abstract]   [Full Text] [Related]  

  • 64. Cefotaxime therapy of bacterial meningitis in children.
    Wells TG; Trang JM; Brown AL; Marmer BC; Jacobs RF
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():181-9. PubMed ID: 6094438
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis.
    Sica DA; Polk RE; Kerkering TM; Patterson P; Baggett J
    Eur J Clin Pharmacol; 1986; 30(6):713-7. PubMed ID: 3464435
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics of ceftizoxime in subjects with various degrees of renal function.
    Kowalsky SF; Echols RM; Venezia AR; Andrews EA
    Antimicrob Agents Chemother; 1983 Aug; 24(2):151-5. PubMed ID: 6314884
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Pharmacokinetic and clinical studies of latamoxef (moxalactam) in neonates and premature infants].
    Fujii R; Hashira S; Takimoto M; Oka T; Yoshioka H; Tsuchida A; Sanae N; Maruyama S; Tojo M; Sunakawa K
    Jpn J Antibiot; 1984 Jun; 37(6):973-90. PubMed ID: 6492388
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetics of netilmicin in premature infants.
    Kuhn RJ; Nahata MC; Powell DA; Bickers RG
    Eur J Clin Pharmacol; 1986; 29(5):635-7. PubMed ID: 3956569
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacokinetics of cefotaxime in neonates and children: clinical aspects.
    von Hattingberg HM; Marget W; Belohradsky BH; Roos R
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():113-8. PubMed ID: 6252139
    [No Abstract]   [Full Text] [Related]  

  • 70. Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.
    Del Rio M; McCracken GH; Nelson JD; Chrane D; Shelton S
    Antimicrob Agents Chemother; 1982 Oct; 22(4):622-7. PubMed ID: 6295262
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacology of kanamycin in the newborn.
    Beachler CW; Speer ME; Mason EO; Yow MD
    South Med J; 1982 Mar; 75(3):301-5. PubMed ID: 7063906
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Pharmacokinetics and clinical effects of cefixime in pediatrics].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita S; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Nagayama K
    Jpn J Antibiot; 1986 Apr; 39(4):1177-200. PubMed ID: 3761546
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical pharmacology of cefotaxime in pediatric patients.
    Kafetzis DA; Brater DC; Kanarios J; Sinaniotis CA; Papadatos CJ
    Antimicrob Agents Chemother; 1981 Oct; 20(4):487-90. PubMed ID: 6282194
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime.
    Wise R; Andrews JM
    Eur J Clin Microbiol; 1983 Oct; 2(5):505-8. PubMed ID: 6315427
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetics of furosemide in neonates.
    Vert P; Broquaire M; Legagneur M; Morselli PL
    Eur J Clin Pharmacol; 1982; 22(1):39-45. PubMed ID: 7094973
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetics and plasma bactericidal activity of aztreonam in low-birth-weight infants.
    Likitnukul S; McCracken GH; Threlkeld N; Darabi A; Olsen K
    Antimicrob Agents Chemother; 1987 Jan; 31(1):81-3. PubMed ID: 3105443
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetics of cefotaxime in neonatal pony foals.
    Gardner SY; Sweeney RW; Divers TJ
    Am J Vet Res; 1993 Apr; 54(4):576-9. PubMed ID: 8484578
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers.
    Meyers BR; Srulevitch ES; Jacobson J; Hirschman SZ
    Antimicrob Agents Chemother; 1983 Nov; 24(5):812-4. PubMed ID: 6318657
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impaired clearance of ceftizoxime and cefotaxime after orthotopic liver transplantation.
    Burckart GJ; Ptachcinski RJ; Jones DH; Howrie DL; Venkataramanan R; Starzl TE
    Antimicrob Agents Chemother; 1987 Feb; 31(2):323-4. PubMed ID: 3551835
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cefotaxime dosage in infants and children. Pharmacokinetic and clinical rationale for an extended dosage interval.
    Kearns GL; Young RA; Jacobs RF
    Clin Pharmacokinet; 1992 Apr; 22(4):284-97. PubMed ID: 1606788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.